Stock Information
Immunitybio Inc (IBRX)
Ticker Symbol: IBRX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $9,632.96 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.3897
Revenue (TTM): $0.11 M
Dividend Yield: N/A%
ROE: -193.29%
Latest News
-
ImmunityBio, Inc. (IBRX) Q4 2025 Earnings Call Transcript
Tue, Mar 3, 2026 11:52 PM
-
Benzinga Bulls And Bears: Rocket Lab, Kosmos Energy, Novo Nordisk — And Nvidia Fails To Boost Markets
Sat, Feb 28, 2026 7:42 AM
-
ImmunityBio Investors Rally Behind Cancer Trial Milestone
Thu, Feb 26, 2026 9:57 AM
-
ImmunityBio Completes Phase 2 Clinical Study Enrollment To Evaluate ANKTIVA Plus Bacillus Calmette-Guérin
Thu, Feb 26, 2026 8:38 AM
-
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase
Wed, Feb 25, 2026 2:02 PM
-
ImmunityBio's 471% Stock Rally Could Enter Next Round If Shorts Capitulate
Wed, Feb 25, 2026 10:09 AM
-
ImmunityBio: Disconnect Between Clinical Progress And Stock Performance
Wed, Feb 25, 2026 7:19 AM
Key Financials
Financial data not available
